Dae-Hee Han, Adam M Leventhal, Andrew C Stokes, Janet E Audrain-McGovern, Sandrah P Eckel, Jessica Liu, Alyssa F Harlow
{"title":"美国成年人的尼古丁-大麻过渡和尼古丁戒断。","authors":"Dae-Hee Han, Adam M Leventhal, Andrew C Stokes, Janet E Audrain-McGovern, Sandrah P Eckel, Jessica Liu, Alyssa F Harlow","doi":"10.1097/EDE.0000000000001855","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prior studies examining the association of cannabis use with nicotine abstinence did not distinguish between individuals co-using nicotine and cannabis versus those who switched from nicotine to exclusive cannabis use; these may have different effects on nicotine abstinence. We examined associations of cannabis use uptake with subsequent nicotine abstinence approximately 1 year later among adults using cigarettes and/or e-cigarettes.</p><p><strong>Methods: </strong>Using six waves of the Population Assessment of Tobacco and Health Study (2013-2021), we assessed transitions from exclusive nicotine use prebaseline (time t ) to (1) exclusive cannabis use, (2) nicotine-cannabis co-use, (3) nonuse of both nicotine and cannabis, and (4) continued exclusive nicotine use at baseline ( t + 1) as exposure variables. Analyses examined associations with nicotine abstinence (from both cigarettes and e-cigarettes) at 1-year follow-up ( t + 2).</p><p><strong>Results: </strong>Among 8382 adults (19,618 observations) reporting exclusive nicotine use prebaseline, 1% transitioned to exclusive cannabis use, 9% to nicotine-cannabis co-use, and 9% to nonuse of both drugs; 81% were still using nicotine exclusively at baseline. Transition to nicotine-cannabis co-use (6%) versus exclusive nicotine use (10%) was inversely associated with nicotine abstinence at follow-up (adjusted relative risk [aRR] = 0.68; 95% confidence interval [CI] = 0.55, 0.83). Transition to exclusive cannabis use (72%) was positively associated with nicotine abstinence compared with continued exclusive nicotine use (10%; aRR = 4.66; 95% CI = 3.83, 5.67) and with similar nicotine abstinence at follow-up (72%) compared with nonuse of both drugs (65%; aRR=0.98; 95% CI = 0.81, 1.18).</p><p><strong>Conclusion: </strong>Co-use of nicotine and cannabis was associated with lower nicotine abstinence. Switching to exclusive cannabis use was associated with similar or greater nicotine abstinence.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"551-559"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nicotine-Cannabis Transitions and Nicotine Abstinence Among United States Adults.\",\"authors\":\"Dae-Hee Han, Adam M Leventhal, Andrew C Stokes, Janet E Audrain-McGovern, Sandrah P Eckel, Jessica Liu, Alyssa F Harlow\",\"doi\":\"10.1097/EDE.0000000000001855\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Prior studies examining the association of cannabis use with nicotine abstinence did not distinguish between individuals co-using nicotine and cannabis versus those who switched from nicotine to exclusive cannabis use; these may have different effects on nicotine abstinence. We examined associations of cannabis use uptake with subsequent nicotine abstinence approximately 1 year later among adults using cigarettes and/or e-cigarettes.</p><p><strong>Methods: </strong>Using six waves of the Population Assessment of Tobacco and Health Study (2013-2021), we assessed transitions from exclusive nicotine use prebaseline (time t ) to (1) exclusive cannabis use, (2) nicotine-cannabis co-use, (3) nonuse of both nicotine and cannabis, and (4) continued exclusive nicotine use at baseline ( t + 1) as exposure variables. Analyses examined associations with nicotine abstinence (from both cigarettes and e-cigarettes) at 1-year follow-up ( t + 2).</p><p><strong>Results: </strong>Among 8382 adults (19,618 observations) reporting exclusive nicotine use prebaseline, 1% transitioned to exclusive cannabis use, 9% to nicotine-cannabis co-use, and 9% to nonuse of both drugs; 81% were still using nicotine exclusively at baseline. Transition to nicotine-cannabis co-use (6%) versus exclusive nicotine use (10%) was inversely associated with nicotine abstinence at follow-up (adjusted relative risk [aRR] = 0.68; 95% confidence interval [CI] = 0.55, 0.83). Transition to exclusive cannabis use (72%) was positively associated with nicotine abstinence compared with continued exclusive nicotine use (10%; aRR = 4.66; 95% CI = 3.83, 5.67) and with similar nicotine abstinence at follow-up (72%) compared with nonuse of both drugs (65%; aRR=0.98; 95% CI = 0.81, 1.18).</p><p><strong>Conclusion: </strong>Co-use of nicotine and cannabis was associated with lower nicotine abstinence. Switching to exclusive cannabis use was associated with similar or greater nicotine abstinence.</p>\",\"PeriodicalId\":11779,\"journal\":{\"name\":\"Epidemiology\",\"volume\":\" \",\"pages\":\"551-559\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/EDE.0000000000001855\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/EDE.0000000000001855","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/31 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Nicotine-Cannabis Transitions and Nicotine Abstinence Among United States Adults.
Background: Prior studies examining the association of cannabis use with nicotine abstinence did not distinguish between individuals co-using nicotine and cannabis versus those who switched from nicotine to exclusive cannabis use; these may have different effects on nicotine abstinence. We examined associations of cannabis use uptake with subsequent nicotine abstinence approximately 1 year later among adults using cigarettes and/or e-cigarettes.
Methods: Using six waves of the Population Assessment of Tobacco and Health Study (2013-2021), we assessed transitions from exclusive nicotine use prebaseline (time t ) to (1) exclusive cannabis use, (2) nicotine-cannabis co-use, (3) nonuse of both nicotine and cannabis, and (4) continued exclusive nicotine use at baseline ( t + 1) as exposure variables. Analyses examined associations with nicotine abstinence (from both cigarettes and e-cigarettes) at 1-year follow-up ( t + 2).
Results: Among 8382 adults (19,618 observations) reporting exclusive nicotine use prebaseline, 1% transitioned to exclusive cannabis use, 9% to nicotine-cannabis co-use, and 9% to nonuse of both drugs; 81% were still using nicotine exclusively at baseline. Transition to nicotine-cannabis co-use (6%) versus exclusive nicotine use (10%) was inversely associated with nicotine abstinence at follow-up (adjusted relative risk [aRR] = 0.68; 95% confidence interval [CI] = 0.55, 0.83). Transition to exclusive cannabis use (72%) was positively associated with nicotine abstinence compared with continued exclusive nicotine use (10%; aRR = 4.66; 95% CI = 3.83, 5.67) and with similar nicotine abstinence at follow-up (72%) compared with nonuse of both drugs (65%; aRR=0.98; 95% CI = 0.81, 1.18).
Conclusion: Co-use of nicotine and cannabis was associated with lower nicotine abstinence. Switching to exclusive cannabis use was associated with similar or greater nicotine abstinence.
期刊介绍:
Epidemiology publishes original research from all fields of epidemiology. The journal also welcomes review articles and meta-analyses, novel hypotheses, descriptions and applications of new methods, and discussions of research theory or public health policy. We give special consideration to papers from developing countries.